<DOC>
	<DOCNO>NCT01240070</DOCNO>
	<brief_summary>Despite several clinical trial clearly demonstrate correction single cardiovascular risk factor patient type 2 diabetes decrease incidence myocardial infarction cardiovascular disease ( CVD ) event , Steno study evaluate effect multifactorial intervention strategy macrovascular complication diabetes . For reason , disease management approach currently endorse international guideline ( i.e correction major CVD risk factor target level usually low low risk population ) extensively investigated term prevalence application current clinical practice term real efficacy . The Multifactorial INtervention type 2 Diabetes - ITaly ( MIND.IT ) multicentric two-phase study involve 9 Diabetes Care Units throughout Italy overall aim : ( 1 ) investigate degree application international guideline CVD prevention type 2 diabetic patient ( 2 ) verify whether application intensive multi-factorial intervention inspire guideline feasible effective decrease incidence new CVD event .</brief_summary>
	<brief_title>Multifactorial Intervention Type 2 Diabetes - Italy</brief_title>
	<detailed_description>The study multi-centric , randomize , open label , active treatment control , two parallel-group , pragmatical intervention trial 5 year follow-up , assess superiority intensive treat-to-target strategy ( include lifestyle pharmacological intervention ) correction major cardiovascular risk factor compare usual care decrease incidence first cardiovascular event non complicate type 2 diabetic patient high risk , define presence 2 cardiovascular risk factor . All high-risk patient identify phase 1 accept participate allocated usual intensive treatment base recruiting center . Centers randomly assign treatment arm phase 2 beginning . Investigators Intensive Care center receive centralized training ensure application intensive care program patient . HbA1c value lipid profile assess peripheral laboratory ( one per study site ) external , centralize , quality control program adjustment systematic difference among study lab . Participating investigator leave free decide upon patient 's treatment . In intensive-care center , investigator provide multi-factorial step-wise protocol support application treat-to-target approach . Intensive care strategy include intervention lifestyle . Dietary intervention goal : BMI &lt; 25 5 % reduction body weight ; dietary assumption saturate fat &lt; 10 % total caloric intake ; fibers= 15-20 g/1000 Kcal . Methods define reach dietary goal : A ) Patients BMI 25-30 kg/m2 : reduction caloric intake = 300-500 Cal/d ; B ) Patients BMI &gt; 30 : reduction caloric intake 500-800 Cal/d . Physical activity intervention goal : 200-300 calorie per day . Example : brisk walk 30 min every day biking ( 18-25Km/h 45-60 min ) . Alternatives : swimming 1h , dance 1h , gym exercise 1h ; -avoiding isometric exercise exercise intensity &gt; 50-60 % maximal oxygen consumption . Frequency : everyday least 3 time week ; Pharmacological intervention : Blood glucose control , multi-step intervention . In obese patient : 1 ) Metformin ( M , 500-2500mg ) ; 2 ) M+Sulphonylureas ( S ) S-like drug , increase progressively dose ; 3 ) M+S+Acarbose ; 4 ) M+S+insulin bed-time ; 5 ) insulin basal-bolus . In normal weight patient : 1 ) S ; 2 ) S+acarbose ; 3 ) S+ bed-time insulin ; 4 ) insulin basal bolus ; Blood pressure control -- &gt; 1 ) Ace-inhibitors AT-II receptor antagonist ; 2 ) add long act calcium-channel blocker beta-blockers low dose diuretic ; 3 ) add third drug ; lipid control : 1 ) diet + physical activity ; 2 ) LDL &gt; 130 mg/dL statin ( stepwise increase dose necessary ) ; triglyceride &gt; 200 mg/dL fibrates ; anti-platelet treatment : aspirin 100 mg/d patient ( alternative drug aspirin-intolerants ) . The scheduled visit define follow : - Intensive-care group : mandatory visit every three month annual visit MIND.IT data collection . - Usual-care group : least one MIND.IT visit every year + usual organization center .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Both gender age 5070 year Type two diabetes least twoyear history disease without insulin treatment first two year diagnosis Negative medical history document previous cardiovascular event macrovascular complication Written consent participate Presence least 2 follow risk factor : LDL cholesterol &gt; 130 mg/dL ( regardless treatment ) Triglycerides &gt; 200 mg/dL HDL cholesterol &lt; 35 ( male ) 45 ( female ) mg/dL Blood pressure &gt; 140/90 mmHg Cigarette smoking Age 50 70 year Type 1 diabetes , diagnosis 40 year age , know presence autoantibody insulin requirement first 2 year disease . Chronic kidney failure ( plasma creatinine &gt; 2 mg/dL ) Significant liver damage ( AST and/or ALT &gt; 2 time upper limit normality ) History previous cardiovascular event Active neoplasm concomitant disease limit life expectancy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>diabetes ,</keyword>
	<keyword>cardiovascular</keyword>
	<keyword>risk factor</keyword>
	<keyword>cardiovascular event</keyword>
	<keyword>intervention</keyword>
</DOC>